Christopher A. Coons

Overview

Senator Christopher A. Coons represents Delaware in the U.S. Senate as a Democrat. With 703 recorded votes across a wide range of policy areas, he has built a voting record that spans healthcare, defense, environment and energy, foreign policy, budget matters, and more. His voting patterns reflect a legislator who consistently supports Democratic positions on most issues while occasionally breaking from his party, particularly on defense and trade matters. On healthcare, Senator Coons has voted in favor of measures aimed at lowering out-of-pocket costs and has supported congressional oversight of federal health agency rules. In the defense arena, he has backed measures requiring congressional authorization for military action, including votes supporting resolutions to direct the removal of U.S. forces from unauthorized hostilities involving Iran. On environment and energy issues, he has supported measures related to chemical safety reporting and environmental regulation. His voting record on trade stands out as an area where he has supported a majority of the measures brought to a vote, with a 66.7% yea rate — one of his highest across all categories. On budget and taxation matters, his voting patterns are more mixed, reflecting a selective approach to fiscal policy proposals. His overall profile is that of a center-left senator who engages substantively across a broad range of policy areas.

Key Positions

• •Voted in favor of requiring congressional authorization before military action against Iran, supporting this position on multiple votes in July 2026.
• •Supported a resolution disapproving of changes to CDC leadership, voting against the confirmation of a nominee for CDC Director in August 2026.
• •Voted to create a procedural safeguard requiring that budget reconciliation legislation demonstrate it would lower out-of-pocket healthcare costs for Americans.
• •Supported maintaining environmental reporting requirements for PFAS chemicals under the Toxic Substances Control Act.
• •Voted against the fiscal year 2027 defense authorization bill in July 2026, suggesting concerns about specific provisions in the legislation.
• •Showed a pattern of opposing many executive branch nominations in the foreign policy and related domains, voting against multiple Treasury and intelligence nominees.
• •Supported trade-related measures at a higher rate (66.7% yea) than most other policy categories, indicating relative openness to trade legislation.